Dermatopathology in the Desert: Dodging Bullets in the Dermatopathology Wilderness

Dermatopathology in the Desert: Dodging Bullets in the Dermatopathology Wilderness is organized by United States and Canadian Academy of Pathology (USCAP) and will be held from Nov 01 - 03, 2020 at USCAP Interactive Center, Palm Springs, California, United States of America.

Accreditation:
The United States and Canadian Academy of Pathology designates this live activity for a maximum of 15.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians can earn a maximum of 15.75 SAM/Part II credit hours.

Course Description:
Differentiating neoplastic from non-neoplastic disorders is one of the most difficult diagnostic challenges in pathology. Accurate diagnosis is paramount to initiate the appropriate treatment. It requires specific skills which often include at least some degree of clinical knowledge, awareness of the broad morphologic range and familiarity with ancillary tests. Errors in the interpretation of skin biopsies, especially in relation to melanocytic tumours, are among the most frequent causes for litigation in surgical biopsy and can lead to unfavorable patient outcomes. There are numerous pitfalls that diagnostic pathologists need to be aware of, including lack of relevant clinical information, sampling error and the wide morphologic spectrum of both inflammatory and neoplastic disorder, often showing overlapping findings and only subtle differentiating features. This special course will elevate your knowledge and polish your diagnostic skills as you interact with experts in a uniquely intimate mentoring environment.

Course Objectives:
• Understand the wide morphologic spectrum of cutaneous tumors and associated diagnostic challenges
• Learn about recent developments in dermatopathology
• Learn how to integrate clinical information and ancillary tests to achieve a better and more precise diagnosis
• Understand the appropriate use and limitations of immunofluorescence testing in dermatopathology